[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537860":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":28,"collaborators":7,"id":32,"slug":7,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":33,"sex":38,"minAge":39,"maxAge":7,"enrollmentInfo":40,"targetDuration":43,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":55,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Erasmus Medical Center","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"DirkJan Hijnen, MD, PhD","CONTACT","0031 10 704 01 10","d.hijnen@erasmusmc.nl",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":7,"country":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"Erasmus University Medical Center","RECRUITING","Rotterdam","Netherlands",{"type":21,"coordinates":22},"Point",[23,24],4.47917,51.9225,{"lat":24,"lon":23},[27],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":29,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","DirkJan Hijnen","Principal Investigator","100537860",false,"NCT06283316","Systemic Treatments for Alopecia Areata Registry","STA2R","Inclusion Criteria:\n\n* Diagnosed with alopecia areata;\n* Starting\u002Fusing a systemic treatment for alopecia areata;\n* Informed consent for registry participation obtained from patient and\u002For caretaker.\n\nExclusion Criteria:\n\n* Not sufficiently capable of understanding the Dutch language;\n* Not willing to participate.","ALL","16 Years",{"count":41,"type":42},10000,"ESTIMATED","50 Years","OBSERVATIONAL","A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.",[47,48,49,50,51,52,53,54],"Alopecia Areata","Alopecia Totalis","Alopecia Universalis","Hair Loss","Hair Diseases","Alopecia","Alopecia Drugs","Autoimmune Diseases",[47,48,49,56,57],"Systemic treatment","Registry","2024-02-27",{"date":60,"type":61},"2024-02-28","ACTUAL",{"date":63,"type":61},"2024-01-17",{"date":65,"type":42},"2099-12-31",{"name":5,"class":6},1]